WinQure Medicine is proud to participate in The Parliament’s Rare Diseases Forum 2026, held today, April 21st, at TownHall Europe in Brussels.
As the EU intensifies its efforts to support over 30 million Europeans living with rare conditions, we are joining policymakers, experts, and patient organizations to help shape the future of healthcare policy. Our attendance focuses on driving the momentum for a comprehensive EU Action Plan on Rare Diseases and navigating upcoming reforms to pharmaceutical law and HTA regulations.
By engaging in the conversation, WinQure Medicine remains committed to:
Translating scientific breakthroughs into real-world care to ensure that no patient is left behind.
Accelerating access to innovative orphan drugs and advanced therapies.
Fostering cross-border collaboration to bridge gaps in research and diagnosis.
Find out more here